Skip to main content

Table 2 Agreement between EHR and chart review for relevant comorbidities

From: Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans

 

Chart Review

 

Overall Agreement

Kappa

(95% CI)

PPA*

(95% CI)

NPA*

(95% CI)

Coronary Artery Disease

96%

0.883

91%

97%

  

(0.724-1.000)

(86-100%)

(86-100%)

Cerebrovascular Disease

88%

0.188

20%

96%

  

(-0.225-0.601)

(0.5-72%)

(84-99%)

Congestive Heart Failure

92%

0.456

50%

96%

  

(0.006-0.905)

(7.0-93%)

(85-100%)

  1. *PPA Positive Percent Agreement (mathematically equivalent to sensitivity), NPA Negative Percent Agreement (mathematically equivalent to specificity)
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us